Cigna taking steps to lower out-of-pocket cost of prescription drugs
Cigna's Evernorth Health Services said on Wednesday its actions will enhance transparency about the company's negotiations.
Healio1d
Pharmacy benefit managers levy 'very significant markups' on drug prices for $7.3B payday
Pharmacy benefit managers overcharged for specialty generic medications — in many cases by hundreds and thousands of percent ...
COBIT1d
An Introduction to Web Client Runtime Security
The term Web Client Runtime Security (WCRS) was coined by the authors to highlight the security or possible malicious behavior of the code executed in users' browsers during their web interactions.
Boston Globe: 'Knock out the middlemen' is a campaign promise Donald Trump should keep
In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.
Woodward News4d
AG office sues CVS Caremark
At least one Woodward pharmacist is celebrating an action by Oklahoma Attorney General Gentner Drummond that could turn the ...
pharmaphorum6d
FTC sues PBMs over 'perverse' rebate system
The lawsuit – which has been anticipated since the FTC published a damning report on the PBM sector in July – names CVS Health's Caremark, UnitedHealth Group's Optum, and Cigna's Express ...
Connecticut-based Cigna announces plan to reduce prescription-drug costs
Bloomfield-based Cigna announced this week a new initiative that aims to reduce out-of-pocket prescription-drug costs and ...
Edward Jones lifts CVS stock rating to buy, sees turnaround potential
Edward Jones, a financial services firm, upgraded CVS Health (NYSE:CVS) stock from Hold to Buy. The upgrade comes as the stock, which InvestingPro analysis shows is currently undervalued, has posted a ...
Leerink raises CVS Health stock price target to $55
Leerink Partners maintained a Market Perform rating on CVS Health (NYSE:CVS) shares while increasing the price target from $51.00 to $55.00. The adjustment reflects the firm's expectation of an ...